Deutsche Bank Maintains Hold on Frontline, Raises Price Target to $19
Deutsche Bank analyst Amit Mehrotra maintains Frontline (NYSE:FRO) with a Hold and raises the price target from $16.5 to $19.
Jefferies Reiterates Buy on Frontline, Maintains $22 Price Target
Jefferies analyst Omar Nokta reiterates Frontline (NYSE:FRO) with a Buy and maintains $22 price target.
Frontline Q4 EPS $0.97 Misses $1.06 Estimate, Sales $530.10M Beat $365.02M Estimate
Frontline (NYSE:FRO) reported quarterly earnings of $0.97 per share which missed the analyst consensus estimate of $1.06 by 8.49 percent. This is a 4950 percent increase over losses of $(0.02) per share from the same
Frontline Registers Over 148% Operating Revenue Growth In Q4 Backed By Recovery In Chinese Demand
Frontline Plc (NYSE:FRO) reported a fourth-quarter operating revenue increase of 148.3% year-over-year to $530.1 million, beating the consensus of $365…
Jefferies Maintains Buy on Frontline, Raises Price Target to $22
Jefferies analyst Omar Nokta maintains Frontline (NYSE:FRO) with a Buy and raises the price target from $17 to $22.
Frontline Announced Earlier Confirmation That It Received From Euronav An Arbitration Request For Proceedings On The Merits Following Frontline’s Decision To Terminate The Combination Agreement
Frontline plc ("Frontline") (NYSE: FRO), formerly Frontline Ltd., confirms that it has received from Euronav NV an arbitration request for proceedings on the merits following Frontline's decision to terminate the combination agreement as further explained in Frontline's press release dated 9 January 2023.
Why VYNE Therapeutics Shares Are Trading Higher By 82%; Here Are 20 Stocks Moving Premarket
Gainers
VYNE Therapeutics Inc. (NASDAQ: VYNE) rose 82.2% to $0.35 in pre-market trading after the company said first vitiligo patient was dosed in Phase 1a/b clinical trial of novel BET inhibitor VYN201.
Euronav Acknowledged Receipt From CMB NV of a Letter to Our Supervisory Board Asking It to Terminate the Combination Agreement With Frontline; Reaffirms Commitment to Combination
Euronav NV ("EURN" or "Euronav") (NYSE: EURN & Euronext: EURN) acknowledges the receipt from CMB NV ("CMB") of a letter to our Supervisory Board asking it to terminate the Combination Agreement with Frontline Ltd. ("Frontline"), following the publication of a 13D filing in relation to the recent increase of its holdings in Euronav.
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday’s Mid-Day Session
Gainers
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.